The emerging therapy of this peptide represents a major breakthrough in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP) – leading to improved glucose regulation and anticip